Politics

Big pharma seizes Brazilian market while medical cannabis bill is stalled

Before the voting of Bill 399, the Government, opposed to the legislation and to the regulation of cannabis cultivation in Brazil, tried to strategically  hinder its advance. 

The Ministry of Health suggested and considered the incorporation of CBD oil into the Universal Health System (SUS, in Portuguese). The only concentration allowed, though, would be 200mg/ml. This attempt to incorporate a product with a very specific concentration would establish Prati-Donaduzzi’s monopoly as the only supplier of CBD oil with the concentration approved by the Brazilian Health Regulatory Agency (ANVISA). On 23 October 2020, the Ministry of Health signed a non-disclosure agreement with Prati-Donaduzzi for technology transfer and technical cooperation.

Original Article (Talking Drugs):
Big pharma seizes Brazilian market while medical cannabis bill is stalled
Artwork Fair Use: André Gustavo Stumpf from Brasil

Anthropology

There will be oil

Anthropology

Cannabis goes green

Politics

Weed wages water war